-
Vertical IntegrationRA Chem Pharma Limited is a vertically integrated pharmaceutical
company Over the past 10 years, it has expanded its spectrum by
establishing state-of-the-art manufacturing facilities in API -
APIAPI division produces under cGMP conditions Active ingredients
and Drug intermediates both for own marketing and custom manufacturing.
The unit is located about 220 km from Hyderabad enroute to Vijayawada
at Jaggaiahpet, Krishna District. -
FormulationsFormulations division is engaged in the manufacture of Finished
Dosage Forms at its plant located at Nacharam, Hyderabad. -
CRBioState of the art, centrally located Clinical Research facility tailored to
meet the constantly evolving needs of formulators
welcome to Ra Chem Pharma Ltd
RA Chem Pharma Limited is a vertically integrated pharmaceutical company.Over the past 10 years, it has expanded its spectrum
by establishing state-of-the-art manufacturing facilities in API, Formulations and Clinical Research.
Facilities
- API Trailblazing synthesis of niche molecules & custom manufacturing. Read more
- Formulations Distinctive entity with meticulous emphasis on solid-dosage forms Read more
- CRBio State of the art, centrally located Clinical Research facility tailored to meet Read more
- Vertical Integration Seamless homogenization of three divisions to empower RA as one. Read more
DEDICATED FACILITIES
-
API Manufacturing at Jaggaiahpet
Custom built API manufacturing site equipped with the latest technology, with a capacity of 210 KL and 7 clean rooms. The facility is inspected and approved by the Drug Control Administration of AP, USFDA, KFDA, PMDA, KFDA and WHO GMP
-
Finished Dosage Forms Manufacturing at Nacharam
Expansive manufacturing unit spread across 5000 m2 exclusively for solid dosage forms, with special emphasis on modified-release formulations. The facility is inspected and approved by USFDA and MoH – Iran.
-
Clinical Research and Biosciences at Balanagar
State-of-the-art, modern facility containing 114 beds and 5 LC-MS/MS and approved by major regulatory authorities including USFDA, EU (Project based), MoH – Turkey, BPFK – Malaysia and UAE MoH.
our Profile
RA Chem Pharma Limited is a vertically integrated pharmaceutical company.Over the past 10 years, it has expanded
its spectrum by establishing state-of-the-art manufacturing facilities in API, Formulations and Clinical Research.
RA GROUP CONSISTS OF
cGMP compliant API manufacturing facility located in Jaggayapet, Krishna District
cGMP compliant solid dosage formulation manufacturing facility at Nacharam,
Board of Directors
Mile Stones
2003
Acquired API facility at Jaggaiahpet
2004
Upgraded the API facility to GMP standards
2005
. API facility was made FDA compliant
. Entered Formulation Business
2006
.Started Clinical Research and Biosciences
.Acquired formulation at Balanagar
2007
USFDA approval for API plant
2008
Obtained MHRA approval for CRBio (Project-based)
2009
.MOH Turkey approval for CRBio
.Japanese approval for API
2010
Expansion of API facility
2011
Expansion of CRBio facility
Vision and Mission
“Our vision is to be a leading pharmaceutical company in India and to become a significant global player by providing high quality, affordable and innovative solutions in medicine and treatment."
Philosophy
RA Chem Pharma was built with a focused, long-term philosophy
Total Quality:
Unwavering commitment to quality in all aspects – from building state-of-the-art facilities and technology, to employees being trained to maintain highest quality and regulatory standards.
Readmore!
Quality Policy
We at RA Chem Pharma Ltdare committed towards a common goal of total customer satisfaction and confidence by providing end to end services to all the clients by continually improving Quality Management System in accordance with cGMP, other regulatory and statutory guidelines.
We shall strive to become globally respected partner driven by strong research & technical capabilities with emphasis on intellectual property and confidentiality.
We as a cohesive & dynamic team shall strive to exceed stakeholders expectations by focusing on customer requirements, empowering employees and maximizing organizational profitability &shareholder wealth.
RACHEM Products
-
API
-
Commercial Products, Manufactured under Exclusivity, New Products for Commercial Launch
-
API Intermediates
-
Lamotrigine, Midazolam, Tamsulosin, Fexofenadine, Entacapone, Donepezil,Pranlukast
-
Formulations
-
Commercialized, Scale up, Development Pipeline, SUSPENSIONS
-
Pre-Formulations Intermediates
-
Commericialized, Underdevelpment